The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Alcoholic Hepatitis Clinical and Translational Network – Basic and Pre-Clinical Research (UH2/UH3)
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on “Translational Research in Alcoholic Hepatitis” to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into “AH Clinical and Translational Network”, hereafter termed “AH Network”. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component.
Through this FOA, applications are sought to conduct basic and pre-clinical studies addressing high impact areas in Alcoholic Hepatitis under the UH2/UH3 Phase Innovation Awards Cooperative Agreement funding mechanism.
- Letter of Intent Due Date(s): September 23, 2017
- Application Due Date(s): October 23, 2017
RFA-AA-18-006 Expiration Date October 24, 2017
Applicants may request up to $275,000 direct costs for the entire UH2 phase with no more than $200,000 direct costs for any year of the UH2 phase. Applicants may request up to $250,000 direct costs for the UH3 phase per year. Budget should reflect the actual needs of the proposed project.